
Full professor Erasmus School of Health Policy & Management Health Economics (HE)
- Location
- Burg. Oudlaan 50, Rotterdam
- Room
- J8-43
- vanbaal@eshpm.eur.nl
‹ Back to overview
Profile
Pieter van Baal is an associate professor of Health Economics. His research focuses on the methodology of cost effectiveness analayses, modeling of diseases/population health and the relation thereof with (non)medical consumption. He has extensive experience in economic evaluations of public health interventions, Markov modeling, uncertainty analyses and is the main developer of PAID (Practical Application to Include future Disease costs). Before working at iBMG/iMTA he was employed by the National Institute for Public Health and the Environment (RIVM) where he was project leader of the RIVM Chronic Disease Model.
- Bram Wouterse, Frederique Ram & Pieter van Baal (2022) - Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands - Value in Health, 25 (5), 731-735 - doi: 10.1016/j.jval.2021.12.008 - [link]
- Muhammad Ashar, Lara Riedige Rohm, Pieter van Baal & Eddy van Doorslaer van Doorslaer (2021) - Improving maternal and child health in Pakistan: a programme evaluation using a difference in difference analysis - BMJ Global Health, 6 (12) - doi: 10.1136/bmjgh-2021-006453
- Klas Kellerborg, Bram Wouterse, Werner Brouwer & Pieter van Baal (2021) - Estimating the costs of non-medical consumption in life-years gained for economic evaluations - Social Science and Medicine, 289, 114414 - doi: 10.1016/j.socscimed.2021.114414 - [link]
- Megan Perry-Duxbury, James Lomas, Miqdad Asaria & Pieter van Baal (2021) - The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS - PharmacoEconomics - doi: 10.1007/s40273-021-01090-x - [link]
- Linda De Vries, Marion Koopmans, Alec Morton & Pieter Van Baal (2021) - The economics of improving global infectious disease surveillance - BMJ Global Health, 6 (9) - doi: 10.1136/bmjgh-2021-006597 - [link]
- Klas Kellerborg, Werner Brouwer, Matthijs Versteegh, Bram Wouterse & Pieter van Baal (2021) - Distributional consequences of including survivor costs in economic evaluations - Health Economics (United Kingdom), 30 (10), 2606-2613 - doi: 10.1002/hec.4401 - [link]
- , Carola Orrego, Marta Ballester, Monique Heymans, Estela Camus, Oliver Groene, Ena Niño de Guzman, Hector Pardo-Hernandez, Rosa Sunol, Aretj Angeliki Veroniki, Carlos Canelo-Aybar, Carola Orrego, Claudia Valli, Claudio Alfonso Rocha Calderón, Cordula Wagner, Dimitri Mavridis, Ena Niño de Guzmán, Estela Camus, Gimon de Graaf, Giorgos Seitidis, Hector Pardo-Hernandez, Jany Rademakers, Jessica Beltrán, Karla Salas, Kevin Pacheco-Barrios, Kaisa Immonen, Lyudmil Ninov, Maria Petropoulou, Marieke van der Gaag, Marta Ballester, Martine Hoogendoorn-Lips, Monique Heymans, Montserrat León, Nina Adrion, Oliver Groene, Rosa Sunol, Pablo Alonso-Coello, Pieter van Baal, Rune Poortvliet, Matthijs Michaël Versteegh, Stella Zevgiti, Jessica Zafra & Valentina Strammiello (2021) - Talking the same language on patient empowerment: Development and content validation of a taxonomy of self-management interventions for chronic conditions - Health Expectations - doi: 10.1111/hex.13303 - [link]
- L M de Vries, K M Kellerborg, W B F Brouwer & P H M van Baal (2021) - Don't forget about the future: The impact of including future costs on the cost-effectiveness of adult pneumococcal conjugate vaccination with PCV13 in the Netherlands - Vaccine, 39 (29), 3834-3843 - doi: 10.1016/j.vaccine.2021.05.091 - [link]
- Klas Kellerborg, Meg Perry-Duxbury, Linda de Vries & Pieter van Baal (2020) - Practical Guidance for Including Future Costs in Economic Evaluations in the Netherlands: Introducing and Applying PAID 3.0 - Value in Health - doi: 10.1016/j.jval.2020.07.004 - [link]
- Meg Perry-Duxbury, M Asaria, J Lomas & Pieter van Baal (2020) - Cured Today, Ill Tomorrow: A Method for Including Future Unrelated Medical Costs in Economic Evaluation in England and Wales - Value in Health, 23 (8), 1027-1033 - doi: 10.1016/j.jval.2020.05.006 - [link]
Master Thesis HE
- Year
- 2021
- Year Level
- master, master
- Course Code
- GW4592M
Master Thesis HEPL
- Level
- master
- Year
- 2021
- Year Level
- master
- Course Code
- GW4555M
Pharmaceutical Pricing and Market Access
- Year
- 2021
- Year Level
- master, master, master, master
- Course Code
- GW4575M
Module Knowledge
- Level
- bachelor 1
- Year
- 2021
- Year Level
- bachelor 1
- Course Code
- GW112K
Public Health Economics
- Year
- 2021
- Year Level
- master, master
- Course Code
- GW4566M